Compass Therapeutics (CMPX) Other Non-Current Assets (2019 - 2026)
Compass Therapeutics (CMPX) reported Other Non-Current Assets of $568000.0 for Q1 2026, little changed on a YoY basis from $568000.0 in Q1 2025, and little changed sequentially from $568000.0 in Q4 2025.
Compass Therapeutics (CMPX) Other Non-Current Assets (2019 - 2026) Analysis & Trends
Compass Therapeutics (CMPX) has 8 years of Other Non-Current Assets data on file, last reported at $568000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets changed 0.0% year-over-year to $568000.0; the trailing twelve-month figure through Mar 2026 stood at $568000.0 (changed 0.0% YoY), and the FY2025 full-year result was $568000.0, changed 0.0% from the prior year.
- Other Non-Current Assets was little changed at $568000.0 in Q1 2026, from $568000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $568000.0 in Q3 2024 to a low of $320000.0 in Q1 2022.
- A 5-year average of $422117.6 and a median of $320000.0 in 2022 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets changed 0.0% in 2022 and jumped 77.5% in 2024, its largest moves.
- Tracing CMPX's Other Non-Current Assets over 5 years: stood at $320000.0 in 2022, then changed by 0.0% to $320000.0 in 2023, then surged by 77.5% to $568000.0 in 2024, then changed by 0.0% to $568000.0 in 2025, then changed by 0.0% to $568000.0 in 2026.
- Business Quant data shows CMPX's Other Non-Current Assets at $568000.0 in Q1 2026, $568000.0 in Q4 2025, and $568000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 60,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 104.24 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 14.48 Mn |
| 10 | Compass Therapeutics | 388.64 Mn | 193.96 Mn | - | 568,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 568,000.00 |
| Dec 31, 2025 | 568,000.00 |
| Sep 30, 2025 | 568,000.00 |
| Jun 30, 2025 | 568,000.00 |
| Mar 31, 2025 | 568,000.00 |
| Dec 31, 2024 | 568,000.00 |
| Sep 30, 2024 | 568,000.00 |
| Jun 30, 2024 | 320,000.00 |
| Mar 31, 2024 | 320,000.00 |
| Dec 31, 2023 | 320,000.00 |
| Sep 30, 2023 | 320,000.00 |
| Jun 30, 2023 | 320,000.00 |
| Mar 31, 2023 | 320,000.00 |
| Dec 31, 2022 | 320,000.00 |
| Sep 30, 2022 | 320,000.00 |
| Jun 30, 2022 | 320,000.00 |
| Mar 31, 2022 | 320,000.00 |
| Dec 31, 2021 | 320,000.00 |
| Sep 30, 2021 | 210,000.00 |
| Mar 31, 2021 | 320,000.00 |